Cargando…

Cefepime-induced neurotoxicity: a systematic review

BACKGROUND: Cefepime is a widely used antibiotic with neurotoxicity attributed to its ability to cross the blood–brain barrier and exhibit concentration-dependent ϒ-aminobutyric acid (GABA) antagonism. Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Payne, Lauren E., Gagnon, David J., Riker, Richard R., Seder, David B., Glisic, Elizabeth K., Morris, Jane G., Fraser, Gilles L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686900/ https://www.ncbi.nlm.nih.gov/pubmed/29137682 http://dx.doi.org/10.1186/s13054-017-1856-1

Ejemplares similares

Cefepime-Induced Neurotoxicity
por: Saini, Tanjot, et al.
Publicado: (2021)

The Trend of Cefepime-Induced Neurotoxicity: A Systematic Review
por: Ajibola, Oluwafemi, et al.
Publicado: (2023)

Characterizing Cefepime Neurotoxicity: A Systematic Review
por: Appa, Ayesha A, et al.
Publicado: (2017)

Cefepime induced neurotoxicity: A case series and review of the literature
por: Isitan, Cigdem, et al.
Publicado: (2017)

Cefepime Neurotoxicity in Patients with Renal Insufficiency
por: Kim, Seon-Yu, et al.
Publicado: (2012)

Cefepime-induced neurotoxicity in a patient with coronary artery bypass
por: Shah, Megha, et al.
Publicado: (2016)

Cefepime-Induced Neurotoxicity in a 74-Year-Old Woman
por: Sharma, Samanvaya, et al.
Publicado: (2022)

Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: Riker, Richard R., et al.
Publicado: (2020)

Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome
por: Riker, Richard R., et al.
Publicado: (2020)

Cefepime-induced Neurotoxicity: Five Cases Reported in a Single Institution
por: Schlidt, Kevin, et al.
Publicado: (2018)

A Case of Cefepime-Induced Neurotoxicity: Renal Function Missing in Action
por: Lichak, Brooke P, et al.
Publicado: (2021)

2528. Cefepime Induced Neurotoxicity in Patients With or Without a History of Seizures
por: Baalbaki, Nadeem, et al.
Publicado: (2023)

Cefepime Neurotoxicity in a Patient With Acute Tubular Necrosis
por: Ojha, Niranjan, et al.
Publicado: (2020)

Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease
por: Nguyen, Dorothy Dao, et al.
Publicado: (2022)

Cefepime-Induced Neurotoxicity or Nonconvulsive Status Epilepticus (NCSE): A Controversy Revisited
por: Shebani, Zacharia, et al.
Publicado: (2023)

2172. Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
por: Groff, Lindsey, et al.
Publicado: (2018)

Cefepime‐induced neurotoxicity in a pediatric patient on chronic hemodialysis: a case report
por: Guzman‐Limon, Monica, et al.
Publicado: (2017)

Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert
por: Cunningham, John M., et al.
Publicado: (2020)

Approach to Cefepime-Induced Neurotoxicity in the Setting of Chronic Kidney Disease: A Case Report and Review of Literature
por: Ruiz de Villa, Ariel, et al.
Publicado: (2022)

Assessing the association between cefepime percentage free trough level and neurotoxicity
por: Zia, Aleena, et al.
Publicado: (2022)

Cefepime: Cefepime-induced encephalopathy: case report
Publicado: (2022)

Cefepime-Induced Encephalopathy
por: Keerty, Dinesh, et al.
Publicado: (2021)

Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational Study
por: Wampole, Chelsea, et al.
Publicado: (2022)

Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy
por: Fugate, Jennifer E, et al.
Publicado: (2013)

Cefepime-Induced Neurotoxicity in the Setting of Acute Kidney Injury: A Case Series and Discussion of Preventive Measures
por: Bausch, Severin, et al.
Publicado: (2022)

628. Utilizing Cefepime Therapeutic Drug Monitoring for Patients at Risk of or Exhibiting Signs of Neurotoxicity
por: Au, Joanna, et al.
Publicado: (2022)

Cefepime-induced encephalopathy
por: Kenzaka, Tsuneaki, et al.
Publicado: (2018)

Cefepime-Induced Delirium
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Cefepime-Induced Neurotoxicity Can Be Confused With Neuroleptic Malignant Syndrome, Catatonia and Serotonin Syndrome: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Evaluation of Free Valproate Concentration in Critically Ill Patients
por: Brown, Caitlin S., et al.
Publicado: (2022)

Cefepime-induced encephalopathy with normal renal function
por: Meillier, Andrew, et al.
Publicado: (2016)

In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae
por: Crandon, Jared L., et al.
Publicado: (2015)

Derivation and Validation of a New Equation for Estimating Free Valproate Concentration in Critically Ill Adult Patients
por: Liu, Ji Tong, et al.
Publicado: (2023)

Bispectral index and suppression ratio are very early predictors of neurological outcome during therapeutic hypothermia after cardiac arrest
por: Seder, D, et al.
Publicado: (2007)

Cefepime-Induced Neutropenia: A Case Report and Literature Review
por: Koraysh, Somaya, et al.
Publicado: (2023)

Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-analysis
por: Jan, Saber, et al.
Publicado: (2018)

1100. A Prospective Evaluation of Neurotoxicity Among Patients Receiving Dose-Optimized Cefepime or Meropenem With Concomitant Therapeutic Drug Monitoring
por: Smith, Brandon, et al.
Publicado: (2021)

Continuous Infusion of High Doses of Cefepime in Intensive Care Unit: Assessment of Steady-State Plasma Level and Incidence on Neurotoxicity
por: Jean-Michel, Vanessa, et al.
Publicado: (2022)

In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0bi35kkod1qko4li9shor0trmk